Literature DB >> 16025514

Mesenteric Th1 polarization and monocyte TNF-alpha production: first steps to systemic inflammation in rats with cirrhosis.

Leticia Muñoz1, Agustín Albillos, Mónica Nieto, Eduardo Reyes, Lourdes Lledó, Jorge Monserrat, Eva Sanz, Antonio de la Hera, Melchor Alvarez-Mon.   

Abstract

A systemic inflammatory state with increased circulating tumor necrosis factor alpha (TNF-alpha) has been related to the bacterial infection susceptibility and hemodynamic derangement of patients with cirrhosis. We compared the activation status of immune cell subpopulations defined by 4-color cytometry in mesenteric and peripheral lymph nodes and blood of rats with CCl(4)-cirrhosis to define the immune response initiation site, the T-cell and monocyte contribution to pro-inflammatory cytokine production, as well as the pathogenic role of enteric bacteria in the cirrhosis immune response. Th1 cells and monocytes were expanded in the mesenteric nodes (P < .001) and blood (P < .001) of rats with cirrhosis, and activated to produce interferon gamma (P < .0001) and TNF-alpha (P < .0001), respectively. The greater numbers of recently activated CD134(+) Th cells in mesenteric nodes compared with blood, the correlation between their numbers in mesenteric nodes and blood (r = 0.66, P < .001), and the expansion of activated CD45RC(-) Th cells, which are unable to re-enter lymph nodes, in mesenteric nodes but not in blood or axillary nodes points to mesenteric nodes as the origin site of activated Th cells. Abrogation of bacterial translocation by bowel decontamination reduced the number of activated Th cells and monocytes, and normalized interferon gamma production by Th cells and TNF-alpha production by monocytes in mesenteric nodes and blood, respectively. In conclusion, in cirrhosis, enteric bacteria start off an orchestrated immune response cascade in mesenteric nodes involving Th1 polarization and monocyte activation to TNF-alpha production. Later, the recirculation of these activated effector immune cells into blood promotes systemic inflammation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16025514     DOI: 10.1002/hep.20799

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  19 in total

1.  Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications.

Authors:  Georgios I Tsiaoussis; Stelios F Assimakopoulos; Athanassios C Tsamandas; Christos K Triantos; Konstantinos C Thomopoulos
Journal:  World J Hepatol       Date:  2015-08-18

2.  Vitamin D status and expression of vitamin D receptor and LL-37 in patients with spontaneous bacterial peritonitis.

Authors:  Chong Zhang; Lianrong Zhao; Li Ma; Cheng Lv; Yang Ding; Tingting Xia; Jingyan Wang; Xiaoguang Dou
Journal:  Dig Dis Sci       Date:  2011-07-14       Impact factor: 3.199

Review 3.  Leaky gut and the liver: a role for bacterial translocation in nonalcoholic steatohepatitis.

Authors:  Yaron Ilan
Journal:  World J Gastroenterol       Date:  2012-06-07       Impact factor: 5.742

Review 4.  Cirrhosis-associated immune dysfunction.

Authors:  Agustín Albillos; Rosa Martin-Mateos; Schalk Van der Merwe; Reiner Wiest; Rajiv Jalan; Melchor Álvarez-Mon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-10-26       Impact factor: 46.802

Review 5.  Liver cirrhosis and immune dysfunction.

Authors:  Elda Hasa; Phillipp Hartmann; Bernd Schnabl
Journal:  Int Immunol       Date:  2022-09-06       Impact factor: 5.071

6.  Toll-like receptor 2-mediated intestinal injury and enteric tumor necrosis factor receptor I contribute to liver fibrosis in mice.

Authors:  Phillipp Hartmann; Michael Haimerl; Magdalena Mazagova; David A Brenner; Bernd Schnabl
Journal:  Gastroenterology       Date:  2012-07-27       Impact factor: 22.682

Review 7.  Clinical and pathophysiological consequences of alterations in the microbiome in cirrhosis.

Authors:  Jane Macnaughtan; Rajiv Jalan
Journal:  Am J Gastroenterol       Date:  2015-09-29       Impact factor: 10.864

Review 8.  The gut microbiome and liver cancer: mechanisms and clinical translation.

Authors:  Le-Xing Yu; Robert F Schwabe
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-07-05       Impact factor: 46.802

Review 9.  Inflammation: a way to understanding the evolution of portal hypertension.

Authors:  María-Angeles Aller; Jorge-Luis Arias; Arturo Cruz; Jaime Arias
Journal:  Theor Biol Med Model       Date:  2007-11-13       Impact factor: 2.432

10.  The Relationship between Renal Dysfunction and Abnormalities of the Immune System in Patients with Decompensated Cirrhosis.

Authors:  Eiji Kakazu; Yasuteru Kondo; Tooru Shimosegawa
Journal:  ISRN Gastroenterol       Date:  2012-12-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.